Doris Loveday Carver passed away peacefully on Feb. 11, 2024, at Our Lady of the Lake Regional Medical Center at age 77 after a long struggle in the hospital.
Together with previous research, this analysis suggests a new therapeutic approach for treating anemia in the CKD population. Ziltivekimab, an anti-IL-6 ligand antibody, increases iron and other anemia parameters in patients with chronic kidney disease (CKD).
A new study demonstrated hemoglobin levels significantly increased with ziltivekimab, showing the monoclonal antibody has the potential to serve as a new treatment method for anemia.
Panoramic Health Propels Integrated Value-Based Care in Texas Through a Strategic Partnership With San Antonio Kidney Disease Center kansascity.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kansascity.com Daily Mail and Mail on Sunday newspapers.